Transglutaminase Market Set to Reach US$ 967.5 Mn by 2031 - Persistence Market Research

The global transglutaminase market, also known as the "meat glue" market, is poised for remarkable growth driven by expanding applications in the food processing industry. As of 2021, the market stands at a valuation of US$ 474.1 Mn and is projected to double, reaching US$ 967.5 Mn by the end of 2031, growing at a healthy CAGR of 7.4%. The primary use of transglutaminase lies in its ability to improve the texture and appearance of processed food items, particularly in meat, fish, dairy, and bakery applications.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response):
https://www.persistencemarketresearch.com/samples/31684

Europe emerges as the leading geographical region, accounting for over 29% of the market share, with France witnessing a notable growth trajectory. This dominance is attributed to the region's growing demand for clean-label ingredients and natural food processing aids. Fish processing leads as the top application segment, projected to reach US$ 312.7 Mn by 2031, while microbial fermentation (MTGs) remains the preferred source due to its sustainable and cost-effective nature.

Key Highlights from the Report

➤ The global transglutaminase market is forecasted to expand at a CAGR of 7.4% between 2021 and 2031.
➤ Europe holds the highest regional value share of over 29% in the global market.
➤ Microbial Fermentation (MTGs) accounts for a dominant 80.3% share of the market by source type.
➤ The fish processing segment is projected to be the most lucrative application, valued at US$ 312.7 Mn by 2031.
➤ India leads the South Asia & Pacific market, with a value CAGR of 9.4%.
➤ France is the fastest-growing country in Europe, anticipated to grow at a CAGR of 7.3%.

Market Segmentation

The transglutaminase market is segmented based on source and application, offering insights into diverse usage patterns.

From a source perspective, the market is divided into animal and plant tissues (TTGs) and microbial fermentation (MTGs). Among these, microbial fermentation dominates the market due to its ease of production, cost-effectiveness, and broader scope of application. With increasing consumer aversion to animal-based ingredients, MTGs have become the industry standard.

In terms of application, transglutaminase is widely used in meat processing, fish processing, dairy products, and bakery products. Fish processing holds the highest market share, followed closely by meat and dairy. The enzyme's role in enhancing texture and structural integrity of food makes it invaluable for manufacturers looking to meet rising consumer expectations for premium food quality.

Regional Insights

Globally, the European market continues to lead with the highest value share, driven by strong demand for clean-label and natural food processing ingredients. Countries like France are expected to grow rapidly due to increased industrial applications and supportive regulatory frameworks promoting enzyme-based solutions.

Asia Pacific, particularly India, is projected to see the highest CAGR of 9.4%, fueled by the rising popularity of processed and convenience foods. India alone holds a substantial 47.21% share of the South Asia & Pacific market, indicating high potential for market entrants and investors.

Meanwhile, North America and East Asia are also witnessing increased adoption of transglutaminase enzymes, particularly in meat alternatives and high-protein processed foods, reflecting broader health and nutrition trends.

Market Drivers

A primary driver of the transglutaminase market is the growing demand for fermented foods, which are known for their health benefits. Foods such as yogurt, cheese, kimchi, and fermented fish rely on enzymatic processes where transglutaminase plays a crucial role in accelerating fermentation and enhancing nutrient availability.

The increasing consumer preference for natural and clean-label food products has further propelled the demand for microbial-sourced transglutaminase. This enzyme helps improve product stability and texture without relying on artificial additives, aligning with the rising trend of transparency in food labeling.

In addition, research and development investments in enzyme technology and food innovation have opened new avenues for transglutaminase, especially in the medical field for treating conditions like idiopathic pulmonary fibrosis (IPF) and celiac disease, where the enzyme's role in tissue remodeling is under active investigation.

Market Restraints

Despite its promising growth, the transglutaminase market faces notable restraints. One significant challenge is the rising popularity of non-GMO and organic food products. Since most commercial enzymes are derived from genetically modified microorganisms, consumers wary of GMOs tend to avoid products containing such enzymes.

Health concerns also persist, particularly with MTG's potential impact on celiac disease. Scientific studies suggest that microbial transglutaminase may trigger immune responses in sensitive individuals, making it a controversial additive for gluten-free or health-focused food products. This can affect consumer trust and limit adoption in certain markets.

Market Opportunities

The transglutaminase market is ripe with opportunities, particularly in innovative food formulation and health-centric applications. As the plant-based and alternative protein industry grows, so does the demand for enzymes that can enhance the texture, binding, and shelf-life of these products-an area where transglutaminase excels.

Furthermore, the pharmaceutical and biomedical fields are exploring the enzyme's potential in tissue engineering and drug delivery. This includes its application in stabilizing extracellular matrices and aiding in cancer treatment pathways, which could unlock entirely new revenue streams.

Growing awareness of food sustainability and the need to reduce waste has also opened doors for transglutaminase to be used in restructuring meat scraps and improving yield efficiency in food production, aligning with the global goals of sustainable development.

Frequently Asked Questions (FAQs)

◆ How big is the transglutaminase market in 2024?
◆ Who are the key players in the global transglutaminase market?
◆ What is the projected growth rate of the transglutaminase market between 2021 and 2031?
◆ What is the market forecast for transglutaminase enzymes by 2032?
◆ Which region is estimated to dominate the transglutaminase industry through the forecast period?

Company Insights

Prominent companies in the global transglutaminase market include:
• BDF Ingredients
• C&P Group Ingredients
• Creative Enzymes
• Guangdong Kelong Biotechnology Co., Ltd.
• Haihang Industry
• Jiangsu Yiming Biological Technology Co., Ltd.
• Micro-Tech Foods Ingredients, Inc.
• Ultreze Enzymes Pvt. Ltd.
• Yesil Arma
• Ajinomoto Co., Inc.
• Antozyme Biotech Pvt. Ltd.
• Apex Biotechnol

Contact Us:
Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:
At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 25.92, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.